AcureX%20logo_edited_edited.png
  • Home

  • Leadership

  • Pipeline

  • Publications

  • News

  • Careers

  • Contact

  • More

    Use tab to navigate through the menu items.

    Key Publications

    A Mitochondrial Membrane-Bridging Machinery Mediates Signal Transduction of Intramitochondrial Oxidation. Nat. Metab. 2021.

    ​

    Editorial: MIC60 Relays Oxidation to Block Mitophagy. Nat Metab. 2021.

    ​

    Miro1 Impairment in a Parkinson’s At-Risk Cohort. Front. Mol. Neurocsi. 2021;14,1–8.

    ​

    Precision Neurology for Parkinson's Disease: Coupling Miro1-Based Diagnosis with Drug Discovery. Mov. Disord. 2020.

    ​

    Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models. Cell Metab. 2019; 1131–1140.

     

    Alpha-Synuclein Delays Mitophagy and Targeting Miro Rescues Neuron Loss in Parkinson’s Models. Acta Neuropathol. 2018;136: 607–620. 

    ​

    Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson’s Disease. Cell Stem Cell. 2016;19: 709–724.

    © 2022 AcureX Therapeutics. All rights reserved.